Support PenkeMoonLake Immunotherapeutics - Trending symbols
Latest News of MoonLake Immunotherapeutics
| Date | Title | Read |
|---|---|---|
| 2025-11-21 12:08 | MLTX SHAREHOLDERS: A Securities Class Action against MoonLake Immunotherapeutics has been Filed on behalf of Investors -- Contact BFA Law by December 15 | Read |
| 2025-11-19 14:08 | MLTX STOCK: MoonLake Immunotherapeutics Sued for Securities Fraud after Drug Trial Results Cause 90% Stock Drop -- Investors Notified to Contact BFA Law | Read |
| 2025-11-18 14:50 | MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MLTX | Read |
| 2025-11-18 12:15 | MLTX INVESTOR ALERT: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law | Read |
| 2025-11-17 17:30 | MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm | Read |
| 2025-11-17 15:00 | MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline | Read |
| 2025-11-17 14:08 | MLTX STOCK LOSS: MoonLake Immunotherapeutics Faces Securities Fraud Class Action due to Drug Trial Results – Contact BFA Law if You Suffered Losses | Read |
| 2025-11-15 12:36 | STOCK ALERT: MoonLake Immunotherapeutics (MLTX) Investors may be Eligible for Compensation in Securities Class Action – Contact BFA Law by December 15 Deadline | Read |
| 2025-11-14 19:58 | MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman | Read |
| 2025-11-14 18:08 | DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders | Read |
Trends
| 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income Tax Expense | 92 | -51 | 41 | 112 | 153 | -58 | 95 | -210 | -115 | |
| Long-term Assets Other | 8,423 | -2,105 | 6,319 | -2,190 | 4,129 | -2,065 | 2,065 | -267,335,364 | -267,333,299 | |
| Depreciation and Amortization | 3 | 20 | 23 | 5 | 28 | 4 | 33 | -116 | -83 | |
| Operating Income | -15,029 | -4,792 | -19,820 | -10,758 | -30,578 | -12,534 | -43,112 | 136,623 | 93,511 | |
| Total Other Income Expense Net | 7,186 | -1,271 | 5,915 | -17 | 5,898 | 1,192 | 7,090 | -120,988,194 | -120,981,104 |
Comments
How you think about this?